S

Samil Pharmaceutical Co Ltd
KRX:000520

Watchlist Manager
Samil Pharmaceutical Co Ltd
KRX:000520
Watchlist
Price: 10 350 KRW -0.19% Market Closed
Market Cap: 224.5B KRW

Samil Pharmaceutical Co Ltd
Tax Provision

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Samil Pharmaceutical Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
S
Samil Pharmaceutical Co Ltd
KRX:000520
Tax Provision
â‚©2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Tax Provision
-â‚©7.5B
CAGR 3-Years
39%
CAGR 5-Years
34%
CAGR 10-Years
12%
SK Biopharmaceuticals Co Ltd
KRX:326030
Tax Provision
â‚©145.8B
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Tax Provision
-â‚©27.2B
CAGR 3-Years
4%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Tax Provision
-â‚©13.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-17%
C
Caregen Co Ltd
KOSDAQ:214370
Tax Provision
-â‚©5.9B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Samil Pharmaceutical Co Ltd
Glance View

Market Cap
219.7B KRW
Industry
Pharmaceuticals

SAMIL PHARMACEUTICAL Co., Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Seoul, Seoul. The Company’s products portfolio consists of gastro-intestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives under the brand names of Plybutine, Gliptide and others; antipyretic, analgesic and anti-inflammatory agents under the brand name Brufen; nutritional supplements such as vitamins, minerals and immunosuppressants, and others including antigout agents, anti-parkinsonism agents and others. In addition, it is engaged in the provision of miscellaneous goods. The firm distributes its products within domestic market and to overseas markets. On November 29, 2013, it transferred its entire shares of a Korea-based company, which is engaged in the sale of medical products.

Intrinsic Value
9 339.45 KRW
Overvaluation 10%
Intrinsic Value
Price
S

See Also

What is Samil Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
2B KRW

Based on the financial report for Jun 30, 2025, Samil Pharmaceutical Co Ltd's Tax Provision amounts to 2B KRW.

Back to Top